Tristel plc
("Tristel" or the "Company")
Director/PDMR Shareholding
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products announces that, on 1 April 2025, Liz Dixon , Chief Financial Officer of the Company, purchased 5,000 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 291.99 pence per Ordinary Share.
As a result, Liz Dixon's beneficial interest in the Company is 155,000 Ordinary Shares, representing 0.32 per cent. of the total issued share capital.
For further information please contact:
| Tristel plc | Via Walbrook PR | |
| Matt Sassone, Chief Executive Officer | ||
| Liz Dixon, Chief Financial Officer | | |
| | | |
| Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com | |
| Paul McManus | Mob: 07980 541 893 | |
| Lianne Applegarth | Mob: 07584 391303 | |
| | | |
| Cavendish Capital Markets Limited | Tel: 020 7220 0500 | |
| Geoff Nash / Camilla Hume / Trisyia Jamaludin (Corporate Finance) | | |
| Sunila de Silva (ECM) Louise Talbot (Sales) | | |
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014 which forms part of UK Law by virtue of the European Union (Withdrawal) Act 2018.
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Liz Dixon |
| 2. | Reason for the Notification | |
| a) | Position/status | CFO |
| b) | Initial notification/Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Tristel plc |
| b) | LEI | 2138009DZ4LH9CZGF662 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of 1p each |
| Identification code | GB00B07RVT99 | |
| b) | Nature of the transaction | Purchase of Ordinary Shares |
| c) | Price(s) and volume(s) | 291.99 pence, 5,000 shares
|
| d) | Aggregated information: · Aggregated volume · Price | See above
|
| e) | Date of the transaction | 1 April 2025 |
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON)
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.